glp 1 analogue drugs GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Glucagon-like peptide-1 receptor: mechanisms and

Clinical trials show average weight loss of 15% to 22% of total body weight, depending on the specific medication and dosage used

Retatrutide also works on the glucagon receptor, which may help the body use more energy and break down fat more effectively

8H) and FGF21 levels at 72 h (Fig

Continued tirzepatide therapy sustained and even augmented initial weight loss, whereas discontinuation resulted in marked weight regain, confirming its durable effectiveness and good tolerability for long-term weight management (31)

While these medications offer potential healthcare savings by reducing obesity-related conditions, their high cost (approximately $1,000 per month in the US) poses significant challenges for healthcare budgets and raises questions about cost-effectiveness and equitable access